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Central or nephrogenic diabetes insipidus (DI) is an extremely rare entity encountered in neonates. Neonatal central DI (CDI) has an incidence of approximately 
2/100,000 live births [1]. The common underlying etiologies of 
neonatal DI include infections such as meningitis, congenital 
viral infections, intraventricular hemorrhage, hypoxic-ischemic 
encephalopathy, and cerebral malformations such as septo-optic-
dysplasia, holoprosencephaly, hydranencephaly, corpus callosum 
agenesis, and familial pituitary hypoplasia. Persistent polyuria 
with hypernatremic dehydration with low weight gain, despite 
adequate treatment, should arouse the suspicion of neonatal DI [2].
Hydranencephaly is an uncommon congenital anomaly 
characterized by necrosis of the cerebral hemispheres and its 
replacement by a membranous sac containing cerebrospinal fluid. 
The pathogenesis is thought to be intrauterine bilateral internal 
carotid artery occlusion at the gestational age of 8–12 weeks. 
The various etiologies include maternal infections, drugs, and 
multiple gestations. The spectrum of symptoms includes lethargy, 
feeding difficulties, feeble crying, irritability, hypertonia, and 
seizures [3]. Here, we present a case with antenatally diagnosed 
hydranencephaly with neonatal CDI. This is the first such reported 
case to the best of our knowledge in our country.
CASE REPORT
Our case, a male baby full-term vaginal delivery weighing 3 kg 
(50th centile) was born to a primigravida mother without any 
antenatal risk factors. The antenatal ultrasound at the 7th month 
was suggestive of massive hydrocephalus. A fetal magnetic 
resonance imaging (MRI) was performed in the 8th month of 
gestation which was reported as hydranencephaly (Figs. 1 and 2).
At birth, examination did not reveal any dysmorphic features. 
Head circumference was 35 cm (10th to 50th centile), and total 
length was 48 cm (50th centile). There was generalized hypotonia, 
and rest of the systemic examination was normal. The baby was 
admitted to neonatal intensive care unit for his poor activity on 
day of life one.
From the 4th day of life, he started having dehydration and 
was found to be polyuric, urine output being around 6 ml/kg/h. 
On further evaluation, the baby had hypernatremia along with 
persistent polyuria (Table 1). He was treated according to the 
protocol for the management of hypernatremic dehydration. 
Simultaneously, investigations were sent for the evaluation of 
polyuria which included serum and urine osmolality with urinary 
electrolytes. The reports were suggestive of high serum osmolality 
(343.2 mOsmol/L) with low urine osmolality (281.6 mOsmol/L). 
Hence, a diagnosis of DI was made, and the baby was started 
on oral desmopressin (DDAVP) at a dose of 2 µg/kg/day. There 
was a gradual correction of the hypernatremia and polyuria 
after starting oral DDAVP which confirmed the diagnosis of 
CDI. The dose of oral DDAVP was adjusted according to the 
serum electrolytes and urine output, and finally, a dose of 
0.75 µg/kg/day was continued.
He was also evaluated for other hormone deficiencies in the 
hypothalamic axis which were in the normal ranges (thyroid-
stimulating hormone – 2.4 uIU/ml and serum cortisol – 1.2 µg/dl). 
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An MRI brain was planned to look for structural anomalies of 
pituitary gland but could not be done because of non-availability 
in our institute, and a computed tomography scan of the brain 
revealed hydranencephaly. The neonate was discharged on the 26th 
day of life. The baby had an erratic follow-up and unfortunately 
succumbed at 3 months of age.
DISCUSSION
DI is a rare disease in the newborn period. It is a disorder of 
water homeostasis due to absence (central DI) or resistance of the 
kidney to the hormone arginine vasopressin (nephrogenic DI) [2]. 
The diagnosis is difficult because excessive water loss through 
the skin is often attributed as the cause of high serum sodium in 
the neonatal age group thus delaying its medical treatment. This 
condition is characterized by the passage of large amounts of dilute 
urine leading to dehydration and hypernatremia [4]. The clinical 
manifestations of CDI usually occur later, as a result of gradual 
degeneration of the vasopressin-producing neurons [5]. The 
possible etiologies in neonates include birth asphyxia; congenital 
infections such as toxoplasmosis, varicella, and Coxsackie B1 
virus; meningitis; tumors; periventricular hemorrhage; and various 
central nervous system malformations such as holoprosencephaly, 
hydranencephaly, and corpus callosum agenesis [2,6].
Hydranencephaly is one of the malformations attributed to the 
process of vascular disruptions and is caused by occlusion of the 
internal carotid artery in between the 8th and 12th week of gestation. 
The cerebral hemispheres are replaced by a membranous sac with 
the diencephalon and posterior brain structures being relatively 
preserved [3,7,8]. A single gene mutation in FLVCR2 was 
identified recently in one infant with hydranencephaly [7]. The 
pre-disposing conditions include maternal infections, exposure 
to teratogenic agents, twin pregnancies, and fetal genetic 
disorders [8]. Symptomatic management is possible which 
includes measures to reduce intracranial pressure like drugs or 
drainage surgeries. The treatment in hydranencephaly is surgical 
either in the form of shunt placement or a ventriculostomy. 
However, many question the need for surgery in these cases 
when most newborns with this disorder succumb within the 
1st few weeks or months of life although rare cases of children 
with hydranencephaly growing up to adolescence have been 
reported [3].
The key to recognition of DI in neonatal group is to investigate the 
cause for hypernatremia without any other electrolyte abnormalities 
with a proper history and examination for dehydration. The 
diagnostic clincher is a low urine osmolality (< 300 mOsmol/L) 
and high serum osmolality (>300 mOsmol/L) [9]. Our neonate 
had a serum osmolality of 343 mOsmol/L and urine osmolality 
of 281.6 mOsmol/L. Recent studies have used plasma copeptin, 
which is the “C” terminal of arginine vasopressin precursor, as a 
marker for the diagnosis of CDI [2,4]. Further investigations are to 
look for other hypothalamic-pituitary axis hormone involvement, 
sepsis screen, and cranial MRI with high-resolution images of 
the pituitary gland. The normal posterior pituitary lobe contains 
secretory granules which are responsible for hyperintense signal 
on T1-weighted MRI imaging. This finding is absent in idiopathic 
CDI [6]. In our case, other pituitary hormones were within the 
normal limits for age; however, MRI brain could not be done.
The treatment of CDI depends on the type of the condition which 
may include hormone replacement in CDI or drugs such as thiazides 
in the nephrogenic type of DI. Neonatal DI is traditionally treated 
with DDAVP, which is a synthetic analog of vasopressin [10,11]. 
The different routes of administration of vasopressin are intranasal, 
Figure 2: Fetal Magnetic resonance imaging showing cerebrospinal 
fluid-filled cerebral hemispheres
Figure 1: Fetal magnetic resonance imaging showing cerebrospinal 
fluid-filled cerebral hemispheres
Table 1: Serum electrolytes before and after starting DDAVP
Serum electrolytes and urine output Day 1 Day 4 Day 9 Day 14 Day 15 Day 18 Day 19 Day 22
Serum Na (mEq/L) 141 169 186 179 168 161 152 142
Serum K (mEq/L) 4.7 4.0 4.5 4.1 Desmopressin started 4.0 5.1 4.5 3.9
Urine output (mL/kg/h) 5.1 5.1 9.6 9.6 9.2 4.2 3.1 3.6
DDAVP: Desmopressin
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subcutaneous, intravenous, and oral, with the oral route being the 
most commonly used in the treatment of neonatal DI [1]. In our 
case, we used oral DDAVP dissolved in sterile water along with 
breast milk. The oral administration was preferred as it was easy 
to titrate the dose as compared to the intranasal route. The baby 
responded to the therapy and was discharged after adjustment of 
the dose. In a study done by Mavinkurve et al., it was found that 
oral administration of diluted nasal DDAVP was safe and enabled 
proper dose titration [1]. In another case report by Biset and 
Claris et al., in an extremely low birth weight neonate with CDI, 
oral DDAVP was used initially, and the route of administration 
was changed to intranasal before discharge [4]. Titration of the 
dose has to be done while administrating this drug to neonates 
to prevent fluid overload and life-threatening hyponatremia. New 
literature has shown usefulness of thiazide in CDI; however, it is 
not being widely used [10,11].
CONCLUSION
Prompt evaluation of a persistent hypernatremic neonate (not 
responding to routine treatment) for DI is a lifesaving measure. 
Starting DDAVP along with the treatment of the underlying 
etiology in these neonates is mandatory. Dose of DDAVP 
should be adjusted as per the clinical condition and laboratory 
investigations. MRI brain is an important tool in the assessment 
of DI.
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